Back
Editas Medicine, Inc. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
31
EDIT
Editas Medicine, Inc.
Last Price:
$1.98
Seasonality Move:
-14.35%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight buying pressure.
Editas Medicine, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.12 | Sell |
| 20-day SMA: | 2.11 | Sell |
| 50-day SMA: | 2.29 | Sell |
| 200-day SMA: | 2.47 | Sell |
| 8-day EMA: | 0.46 | Buy |
| 20-day EMA: | 0.2 | Buy |
| 50-day EMA: | 0.08 | Buy |
| 200-day EMA: | 0.02 | Buy |
Editas Medicine, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 44.48 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 2.23) | Sell |
| Bollinger Bands (100): | (2.15 - 3.37) | Sell |
Editas Medicine, Inc. Technical Analysis
| Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Editas Medicine, Inc. Stock
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 2.06 while EDIT 8-day simple moving average is 2.12, which is a Sell signal.
-
The stock price of EDIT is 2.06 while Editas Medicine, Inc. 20-day SMA is 2.11, which makes it a Sell.
-
Editas Medicine, Inc. 50-day simple moving average is 2.29 while EDIT share price is 2.06, making it a Sell technically.
-
EDIT stock price is 2.06 and Editas Medicine, Inc. 200-day simple moving average is 2.47, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
31
Editas Medicine, Inc. (EDIT)
is a Sell
Is Editas Medicine, Inc. a Buy or a Sell?
-
Editas Medicine, Inc. stock is rated a SellThe current Editas Medicine, Inc. [EDIT] share price is $2.06. The Score for EDIT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine, Inc. Stock Info
Market Cap:
193.3M
Price in USD:
2.06
Share Volume:
1.3M
Editas Medicine, Inc. 52-Week Range
52-Week High:
4.54
52-Week Low:
0.91
Sell
31
Editas Medicine, Inc. (EDIT)
is a Sell
Editas Medicine, Inc. Share Price Forecast
-
What is the Editas Medicine, Inc. stock price today?The Editas Medicine, Inc. stock price is 2.06 USD today.
-
Will EDIT stock go up or go down?Editas Medicine, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine, Inc. is overvalued.
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 2.06 while EDIT 8-day exponential moving average is 0.46, which is a Buy signal.
-
The stock price of EDIT is 2.06 while Editas Medicine, Inc. 20-day EMA is 0.20, which makes it a Buy.
-
Editas Medicine, Inc. 50-day exponential moving average is 0.08 while EDIT share price is 2.06, making it a Buy technically.
-
EDIT stock price is 2.06 and Editas Medicine, Inc. 200-day simple moving average is 0.02, creating a Buy signal.
Fundamental Analysis of Editas Medicine, Inc.
Is Editas Medicine, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $0.16 per share.
Technical Analysis of Editas Medicine, Inc.
Should I short Editas Medicine, Inc. stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Editas Medicine, Inc. is a Buy
-
Editas Medicine, Inc. Relative Strength Index (RSI) is 44.48, which suggest Editas Medicine, Inc. is oversold
-
The Bollinger Bands (25) for Editas Medicine, Inc. is (2.03 - 2.23), which suggest Editas Medicine, Inc. is a Sell
-
The Bollinger Bands (100) for Editas Medicine, Inc. is (2.15 - 3.37), which suggest Editas Medicine, Inc. is a Sell
* Editas Medicine, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.